Dr Reddy's sells off Tennessee antibiotics facility in restructuring push

Dr Reddy's sells off Tennessee antibiotics facility in restructuring push

Source: 
Biopharma Dive
snippet: 

By 2021, the Indian drugmaker hopes to shift the majority of its North American business from solid oral dosages to injectables.